Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutionsServices Offered: a) Clinical Trial Services: Patient PK trials, Pharmacodynamic endpoint studies, Early & late phase clinical trials, Post-marketing surveillance studies, Investigator initiated and real-world evidence studies, Clinical Trials Support for Complex…
Jeevan Scientific Technology has announced its 28th Annual General Meeting (AGM) will be held on September 25, 2026, at 10:00 a.m. via video conference. Shareholders can vote electronically from September 22 to September 24, 2026, with September 18, 2026, as the cut-off date for eligibility. The company's share transfer books...
Jeevan Scientific Technology Limited secured approval from the Central Drugs Standard Control Organization (CDSCO) for an expanded bed capacity at its Hyderabad Bioavailability/Bioequivalence (BA/BE) Study Centre. Total beds will increase from 132 to 156, and ICU beds from 6 to 8. This expansion, approved after a successful regulatory inspection, significantly...
Jeevan Scientific Technology Limited announced the successful completion of a USFDA inspection at its Bioanalytical Facility in Hyderabad. The inspection, which reviewed studies, operations, and procedures, concluded with zero observations. Inspectors noted the team's strong training, knowledge, and experience with international good practices. This positive outcome highlights JSTL's robust regulatory...
Jeevan Scientific Technology Limited reported to stock exchanges regarding the dematerialization status of its shares. The company's Registrar and Share Transfer Agent confirmed that no requests for converting physical shares to electronic format were received from depositories during the quarter ended June 30, 2026. This indicates no share dematerialization activity...
Jeevan Scientific Technology Limited's Bioavailability/Bioequivalence (BA/BE) Study Centre has successfully completed an inspection by the Central Drugs Standard Control Organization. This inspection was a crucial part of the company's application to add more beds to its existing approved BA/BE center in Hyderabad. The successful conclusion of this regulatory evaluation is...
